Patent · US Active

Treatment of cancer with a RAF inhibitor

US11918587B2 · kind B2 · utility

0Cited by

6References

20Claims

0Family size

Assignee

KINNATE BIOPHARMA INC. · US

Inventors

Aleksandra FRANOVIC · Del Mar, US
Eric Martin · Del Mar, US
Nichol L. G. MILLER · Poway, US
Eric A. Murphy · San Marcos, US
Richard Williams · Newbury Park, US
Ken Kobayashi · Houfu, JP

Key dates

Filing date	Apr 6, 2023
Grant date	Mar 5, 2024
Priority date	—
Expiry date	Apr 6, 2043

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P35/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Provided herein are compositions and methods for the treatment of a cancer. Said compositions comprise a RAF inhibitor. Some embodiments comprise combination therapy featuring the RAF inhibitor with at least one oncology therapeutic agent.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.